US Broker Ratings

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 10.76% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors with its potential upside of 10.76%. Headquartered in..

Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside

Investors with an eye on the healthcare sector may find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling opportunity, as the stock currently suggests a notable potential upside of 48.88%..

Halozyme Therapeutics (HALO) Stock Analysis: A 27.3% Upside Potential Amid Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust growth prospects and potential upside. With a market capitalization of $7.96..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 15.23% Potential Upside Amid Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, is attracting considerable attention from investors with a compelling 15.23% potential upside based on its current trading metrics. With a..

Illumina, Inc. (ILMN)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Compelling 86% Upside Potential for Innovative Healthcare Investors

TransMedics Group, Inc. (TMDX), a pioneering force in the healthcare sector, specifically in medical devices, is capturing the attention of investors with its innovative approach to organ transplant therapy. Headquartered..

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Unlocking 61.53% Potential Upside in Medical Devices

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing the attention of investors with a promising potential upside of 61.53%. Specializing in the healthcare sector, particularly within the medical devices industry, iRhythm..

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator with Over 100% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering force in the biotechnology sector, is making waves with its ambitious efforts to develop next-generation vaccines targeting bacterial infectious diseases. Headquartered in San Carlos,..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare with a Solid Revenue Growth of 23.5%

Humana Inc. (HUM), a prominent player in the U.S. healthcare sector, operates primarily within the healthcare plans industry. With a market capitalization of $36.63 billion, Humana stands as a significant..

Eli Lilly (LLY) Stock Analysis: Leveraging a 20.41% Potential Upside Amid Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, has caught the eye of investors with a market capitalization of $896.13 billion. Known for its innovation in..

Elanco Animal Health (ELAN) Stock Report: A Healthcare Stock with Nearly 50% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Indianapolis, Indiana, Elanco has carved..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 37.51% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the precision oncology sector, has made waves with its innovative approach to cancer diagnostics. The company’s portfolio of cutting-edge tests, including the..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring its 18.37% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $6.62 billion, this American company headquartered..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Giant with a Robust 3.05% Dividend Yield

Merck & Company, Inc. (NYSE: MRK) stands as a towering figure in the healthcare sector, delivering innovative solutions in pharmaceuticals and animal health. Its market cap of $275.09 billion underscores..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 42.40% Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player in the Healthcare sector’s Medical Instruments & Supplies industry, presents a compelling investment case with a potential upside of 42.40%, according to analyst..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Biotech Innovator with 21.91% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, continues to capture the attention of investors with its innovative approach in the healthcare landscape. Based in London,..

The Ensign Group, Inc. (ENSG) Investor Outlook: Exploring a 24% Upside Potential

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With its vast network of skilled nursing,..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: High Growth Potential with 18.69% Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a prominent player in the biotechnology sector, focusing on innovative treatments for central nervous system (CNS) disorders. Headquartered in New York, this biopharmaceutical company..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 55% Potential Upside Amid Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning force in the biotechnology sector, has captured investor attention with its promising pipeline of treatments for genetic diseases and a notable potential upside..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds